SCHEMBL2456836

SCHEMBL2456836

O=C(C(Br)Br)P(=O)(O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23488140 0.71 MMP1 (0.37)
SCHEMBL22856775 0.71 MMP1 (0.37)
SCHEMBL8383247 0.69 MMP2 (0.46)
SCHEMBL3469330 0.67
SCHEMBL2990208 0.65 MMP2 (0.42)
SCHEMBL2916525 0.65 MMP2 (0.42)
SCHEMBL9854945 0.65 CA12 (0.31)
SCHEMBL4409893 0.62
SCHEMBL1906266 0.60 KDM4E (0.38)
Phosphoric Acid SCHEMBL1811052 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8026278-B2 Inhibitors of pyruvate kinase as therapeutic agents for cancer SMITH BRIAN R 2011-09-27 US disclosed
EP-1891082-A4 NOVEL INHIBITORS OF PYRUVATE KINASE AS THERAPEUTIC AGENTS FOR CANCER LEYLAND JONES BRIAN (CA) 2009-02-18 EP disclosed
US-20080311183-A1 Novel Inhibitors of Pyruvate Kinase as Therapeutic Agents for Cancer Leyland-Jones, Brian (CA) 2008-12-18 US disclosed
EP-1891082-A1 NOVEL INHIBITORS OF PYRUVATE KINASE AS THERAPEUTIC AGENTS FOR CANCER Leyland-Jones, Brian (CA) 2008-02-27 EP disclosed
WO-2006125323-A1 NOVEL INHIBITORS OF PYRUVATE KINASE AS THERAPEUTIC AGENTS FOR CANCER DARWIN PHARMA INC (CA) 2006-11-30 WO disclosed